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Synthesis of the title compounds has been
accomplished through dimethyl-2.6-diaryl-4-oxocyclo-
hexane-I, l-dicarboxylates 1. The latter on condensation
with NH2NH2.H20 and NHPH.HCI give 6,lO-diaryl-
2,3-diazaspiro( 4,5)decane-1 ,4,8-triones and 6, IO-diaryl-
2-oxa-3-azaspiro( 4,5)decane-l ,4,8-triones 2 and 3. The
semicarbazones 4 and 5 of 2 and 3 on reaction with
SeOl and SOCll give '5,7-diaryl cyclobexeno[3,4-d]-l-
selena-Z, 3-diazolyl-6-spiro-5'-(2', 3'-pyrazolidine/2', 3'-
oxazolidine)-l ',4'-diones 6,7 and 5,7-diaryl cyclo-
hexeno[3A-d)-I-thia-2,3-diazolyl-6-spiro-5'-(2', 3'-pyra-
zolidine/2',3'-oxazolidine)-l',4'-diones 8,9. The IR and
NMR spectral data correlate to the structures of all the
new compounds.
We have been extensively investigating the
synthetic potential of dimethyl-2,6-diaryl-4-
oxocyclohexane-l,l-dicarboxylates 1 as a source
of a variety of heterocyclic systems I.... It is well
known that a number of heterocyclic compounds
containing nitrogen and sulfur' possess different
pharmacophoric properties. However, reports
about selenium containing heterocycles are
relatively less'", although some of them are used
as chemotherapeutic agents'". In continuation of
our ongoing programme it is felt desirable to
incorporate sulfur/selenium as hetero atoms so that
a new class of condensed spiro-heterocycles
having 2,3-pyrazolidine/2,3-oxazolidine-dione
moieties in combination with I-selenall-thia-2,3-
diazoles could be obtained.
Infact, the synthetic intermediates'? 1 have been
Note
obtained by the Michael addition of dimethyl
malonate to 1,5-diaryl-l ,4-pentadien-3-ones. The
6, 10-diaryl-2, 3-diazaspiro-( 45)decane-l 4 8-
triones 2 and 6,10-diaryl-2-oxa-3-azaspiro-
(4,5)decane-I,4,8-triones 3 nave been prepared on
condensation of 1 with hydrazine hydrate and
hydroxylamine hydrochloride, respectively':'. The
carbonyl group of 2 and 3 is exploited to construct
I-selenall-thia-2,3-diazoles. This has been
achieved by the condensation of 2/3 with
semicarbazide hydrochloride to get semicarba-
zones 4/5 of 2/3. The IR spectrum (vmax em") of 4
showed absorption bands at 1675.and 3200 (C=O
and NH) of pyrazolidinedione moiety and at 3245
(NHCO), 3450 (CONH2), 1660 (CONH2) and 1450
(C=N) of semicarbazone moiety. The absence of a
band at 1700 for carbonyl group of cyclohexanone
confirms the formation of 4. The compound 5 also
exhibited absorption bands nearly in the similar
regions. Besides this, it also exhibited band in the
region 1780 (C=O of 2,3-oxazolidinedione).
Compounds 4 and 5 on cyclization with SeOz and
SOCl2 gave 6/7 and 8/9, respectively. The absence
of bands corresponding to semicarbazone unit in 6-
9 and the presence of bands due to N=N (1520-
1545) in 6-9 and C-S (690-700) in 8 and 9
confirms that the cyclization indeed has taken
place in 4 and 5 (see Scheme I, Table I).
The IH NMR spectra (&, ppm) of 4 and 5 can be
rationalized by presuming that the two aryl groups
at 6 and 10 positions are in true cis-I,3-
arrangement in the preferred rigid chair
conformation of cyclohexane moiety'", although
number of dynamic forms do exist. The methine
(H.J and methylene (HMand Hx) protons of 4 and
5 constitute AMX splitting pattern. The HAdue to
coupling with HMand H, appears as a doublet of
doublet in the downfield region. The HMdue to
geminal and vicinal couplings also appear as a
doublet of.doublet in between HAand Hx. The Hx
also experiences a similar effect and display a
doublet of doublet in slightly upfield region of the
spectrum. A broad singlet for NH is observed not
only in 4 but also in 5. However, the resonance

























(i) NH2NH2 OR NH20H I NaOMa I MaOH
(ii) NH2CONHNH2' CH3COONa , MaOH
signal for NH2 is merged with aromatic protons as
is evidenced by its disappearance on exchange
with D20. The NH of 2,3- pyrazolidinedione and
2,3-oxazolidinedione in 4 and 5 appeared as a
singlet. The 'H NMR spectra of 6-9 exhibited three
sets of signals for methine (Cs-H and C7-H) and
methylene (C.-H) protons of cyclohexene unit. The
C7-H appears as a singlet while Cs-H a triplet and
C.-H a multiplet (see Table I).
Experimental Section
Melting points were determined in open
capillaries and are uncorrected. The purity of the











(iii) 8a02' AcOH 160-700c
(iv) SOCI2' GH2CI2' -10°c
BDH, hexane-ethyl acetate, 2: 1). IR spectra of
compounds were taken in KBr (vrnax, em") on
Perkin-Elmer FT-IR spectrometer and IH NMR
spectra in CDCI) on a varian EM-390 (90 MHz)
spectrometer using TMS as an internal standard
(chemical shift in 8, ppm). The mass spectra (70
eV) of some of the compounds were obtained en
Jeol JMS-D 300 spectrometer. Microanalytical
data were obtained from University of Poona,
Pune, India.
lbe dimethyl-2,6-diaryl-4-oxocyc1ohexane-l, 1-
dicarboxylates'" were obtained by the Michael
addition of dimethyl malonate to 1,S-diaryl-l ,4-
pentadien-3-ones. The compounds were purified
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Table I-Characterization data of compounds 4a-e to 9a-e
Mol. formulat" IH NMR (0, ppm in CDCI3)Compel. Yield m.p.
(%) °C
4a 70 228-29
4b 72 215-18 C23H2SNsOs
4c 69 220-22 CZIH19C12Ns03
4d 72 240-42 C2sH31N703
4e 70 198-200 C17H17NSO)SZ
Sa 68 235-37 C21H20N.O.
Sb 69 220-21 Cz3H2.N.06
Sc 67 225-28 CZ1HlsC12N.O.
Sd 68 210-12 CZSH30N603
Se 66 202-04 C17HI6N.O,S2
6a 70 146-48 CzoH16N•02Se
6b 71 11O-I3(d) CnHzoN.04Se
6c 66 138-40 CzoHl.C12N.02Se
6d 69 120-22 C24Hz6N60ZSe
6e 70 129-31 C16H12N.OzSzSe
7a 70 176-78 CZoH1SN303Se
7b 68 126-28 CnHI9NpsSe
7c 69 165-68 C1oH\3CI1NP3Se
7d 68 140-42 Cl.HzsNs03Se
7e 69 130-33 CI6Hl!Np3SZSe
8a 60 100-03(d) C2oHI6N•OZS
8b 63 125-28@ CnHzoN.O.S
8c 61 115-17 C~I.CI1NPzS
8d 63 130-32 C2oHzSN602S
8e 62 142-44 CI6HI2N.OZS3
2.85 (dd,2H, 7H.&9H.), 3.15 (dd,2H, 7H.&9H.), 4.20 (dd,2H,6H& 10H),
7.56-7.65 (m,12H,Ar-H&NHz),7.70 (s,IH,CONH), 9.30 (s,2H,NH of2,3-
pyrazolidinedione)
2.74 (dd,2H,7H.&9H.), 3.12 (dd,2H,7H.&9H.), 3.34 (s,6H,Ar-OCH3)' 4.24
(dd,2H, 6H&IOH), 7.58-7.69 (m,IOH,Ar-H&NHz},7.72 (s,IH,CONH), 9.92
(s,2H,NH of 2,3-pyrazolidinedione)
2.82 (dd,2H,7H.&9H.), 3.20 (dd,2H,7H.&9H.), 4.16 (dd,2H,6H&10H),
7.44-7.59 (m,8H, Thiophene-H&NHz), 7.70 (s,2H,CONH), 9.76 (s,2H,NH
of 2,3-pyra-zolidinedione)
2.62 (dd,2H,7H.&9H.), 2.98 (dd,2H,7H.&9H.), 4.15 (dd,2H,6H& 10H),
7.50-7.68 (m,12H,Ar-H&NHz),7.75 (5, 1H,CONH), 9.82 (5,IH,NH of2,3-
oxazolidinedione)
2.90 (dd,2H, 7H.&9H.), 3.22 (dd,2H, 7H.&9H.), 4.12 (dd,2H,6H& 1OH),
7.00-7.42 (m,IOH,Ar-H&NHz),7.74 (s,IH,CONH), 9.84 (5,IH,NH of2,3-
oxazolidinedione)
2.78 (dd,2H,7H.&9H.), 3.14 (dd,2H,7H.&9H.), 4.22 (dd,2H,6H&IOH),
7.45-7.60 (rn,8H, Thiophene-Heebl+l.), 7.65 (s,IH,CONH), 9.52 (s,IH,NH
of 2,3-oxazolidinedione)
3.25-3.40 (rn, 2H, C.-H), 4.10 (t,1 H, C~-H), 5.25 (s, 1H, C7-H), 7.10-7.50
(m,1 OH,Ar-H), 9.28 (s,2H,NH of 2,3-pyrazolidinedione)
3.18-3.32 (m, 2H, C.-H), 3.50 (s,6H,Ar-OCH3)' 4.25 (t,1 H, Cs-H), 5.28
(5,1H, C7-H), 7.02-7.48 (m,8H,M-H), 9.18 (s,2H,NH of 2,3-
pyrazolidinedione)
3.24-3.40 (rn, 2H, C,-H), 4.20 (t, 1H, Cs-H), 5.35 (s,1 H, C7-H), 7.14-7.52
(m,oH, Thiophene-H), 9.28 (s,2H,NH of 2,3-pyrazolinedione)
3.38-3.52 (m,2H, C,-H), 4.48 (t,1 H, Cs-H), 5.52 (s, JH, C7-H), 7.20-7.45
(m, 1OH, Ar-H), 10.35 (5,1H,NH of 2,3-oxazolidinedione)
3.45-3.60 (m, 2H, C.-H), 4.36 (t, IH, Cs-H), 5.48 (s,1 H,C7-H), 7.34-7.58
(m8H, Ar-H), 10.40 (s, IH,NH of 2,3-oxazolidinedione)
3.42 -3.57 (m,2H, C.-H), 4.37 (t,1 H, Cs-H), 5.52 (5,1H, C7-H), 7.02-7.38
(m,6H, Thiophene-H), 10.42 (s,1 H,NH of 2,3-oxazolidinedione)
3.28-3.38 (m,2H, C.-H), 4.45 (t,IH, Cs-H), 5.32 (s,IH, C7-H), 7.05-7.48
(m,IOH, Ar-H),9.25 (s,2H,NH of2,3-pyrazolidinedione)
3.35-3.50 (rn, 2H, C.-H), 4.48 (t,1 H, Cs-H), 5.40 (s,1 H, C7-H), 7.15-7.50
(m,8H, Ar-H), 9.30 (s,2H,NH of 2,3-pyrazolidinedione)
3.24-3.32 (rn, 2H, C.-H), 4.46 (t, JH, Cs-H), 5.25 (s, JH, C7-H), 7.00-7.42
(m,6H, Thiophene-H), 9.24 (s,2H,NH of 2,3-pyrazolidinedione)
Contd
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Table I-Characterization data of compounds 4a-e to 9a+-Contd
Mol. formulal" IH NMR (0, ppm in CDCI3)
C2JilSNP3S 3.35-3.51 (m, 2H, C.-H), 4.52 (t,IH, Cs-H), 5.65 (s,IH, C7-H), 7.05-7.34
(m, IOH, Ar-H), 10.34 (s,IH,NH of2,3-oxazolidinedione)
3.28-3.40 (m,2H, C.-H), 3.46 (s,6H,Ar-OCH3)' 4.44 (t,tH, Cs-H), 5.62











ge 3.37-3.50 (m.2H. C.-H), 4.58 (t.1H, Cs-H), 5.45 (s.IH, C7-H), 7.04-7.40
(m,6H,Thiophene-H), 10.30 (s,1 H,NH of 2,3-oxazolidinedione)
"Satisfactory microanalyses were obtained for 4a, 4d, Sb, 6a, 6c, 6e, 7b, 8b, 9a and ge: C± 0.24%, H± 0.15%, N ± 0.18%.
'Molecular ions were observed for 4a, Se, 6e, 7a, 8a and ge at 391, 404, 434, 423, 376 and 389 respectively at 70 eV.
by recrystallization from methanol [ld: m.p. 140-
41°C, yield 65%. Cal. (Found): C, 69.00 (69.21);
H, 7.12 (7.05). Ie: m.p. 148-49°C, yield 75%. Cal.
(Found): C, 57.12 (56.95); H, 4.79 (4.87)].
The 6,1 0-diaryl-2,3-diazaspiro( 4,5)decane-l, 4,
8-triones/6, 10-diaryl-2-oxa-3-azaspiro( 4, 5)-de-
cane-l,4,8-triones (2 and 3) were prepared by the
condensation of I with NH2NH2.H20 and
NH20H.HCI3.4. The compounds were purified by
recrystallization from methanol [2d: m.p. 225-
27°C, yield 69%. Cal (Found): C, 68.55 (68.35); H,
6.71 (6.78); N, 13.32 (13.50). 2e: m.p. 199-01°C,
yield 70%. Cal (Found): C, 55.47 (55.62); H, 4.07
(4.14). 3d: m.p. 186-87°C, yield 65%. Cal
(Found): C, 68.39 (68.19); H, 6.45 (6.37); N, 9.96
(9.85). 3e: m.p, 204-06°C, yield 67%. Cal.
(Found): C, 55.31 (55.52); H, 3.77 (3.85)].
8-Semicarbazono-6, lO-diaryl-2, 3-diazaspiro-
(4,5)decane-l,4-diones/6, lO-diaryl-2-oxa-3-aza-
spiro(4, 5)decane-l, 4-diones 4/5. General pro-
cedure. Semicarbazide hydrochloride (0.017 mole)
and sodium acetate trihydrate (0.03 mole) were
dissolved in ethanol (40 mL) and the solid, if any,
formed was filtered off. To this, compound 2
(0.0029 mole) in ethanol was added and the
contents were refluxed for 4-5 hr on a steam-bath.
The reaction mixture was then concentrated,
cooled and poured onto crushed ice. The separated
solid was filtered, washed thoroughly with cold
water, dried and recrystallized from ethanol to get
pure 4/5.
5,7-Diarylcyclobexeno[3, 4-d]-I-selena-2,3-di-
azolyl-6-spiro-5' -(2' ,3' -pyrazolidine/2', 3' -oxa-
zolidine)-l ',4'-diones 617. General procedure.
The semicarbazone 3 (0.0025 mole) in glacial
acetic acid (20 mL) was warmed while stirring in
order to get a clear solution. Selenium dioxide
powder (0.0025 mole) was then added in portions
and continued the stirring while maintaining the
temperature at 60-70°C until the evolution of gas
ceased. The reaction mixture was then allowed to
attain room temperature and the deposited
selenium was removed by filtration. When the
filtrate was poured on crushed ice, a solid product
was separated. It was filtered and washed
thoroughly with cold water and sodium
bicarbonate solution. The product obtained was
purified by chromatography.
5,7-Diaryl cyclobexeno[3, 4-d]-1-tbia-2, 3-di-
azolyl-6-spiro-5' -(2', 3' -pyrazolidine/2', 3' -oxa-
zolidine)-l ',4'-diones 8/9. General procedure.
The semicarbazone 3 (0.0025 mole) was added
portion-wise to an excess of thionyl chloride (5
ml.) maintained at -5 to -10°C and allowed to
reach the room temperature where it was kept for a
further period of 1-2 hrs. The reaction mixture was
diluted with 30 mL of dichloromethane and treated
with ice-cold solution of sodium carbonate. The
organic layer was separated and w.ashed repeatedly
with water and then dried over anhydrous sodium
sulfate. Evaporation of the solvent gave a gummy
substance which was solidified by triturating with
petroleum ether (40-60°). The crude product
obtained was purified by column chromatography.
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